Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.32 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31735314 | 0.85 | LMNA (0.72) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL7561007 | 0.85 | ALDH1A1 (0.50) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL4572237 | 0.81 | — | — | |
| SCHEMBL18643102 | 0.81 | NFE2L2 (0.33) | MEN1LMNATHRBBLMKMT2A | |
| SCHEMBL8128719 | 0.78 | — | — | |
| SCHEMBL195170 | 0.78 | — | — | |
| SCHEMBL6828181 | 0.78 | — | — | |
| SCHEMBL196275 | 0.78 | — | — | |
| SCHEMBL371078 | 0.78 | — | — | |
| SCHEMBL10678897 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0268039-B1 | 3-TERT-BUTYL AND 3-TERT-BUTYL-5-ALKYL-4-HYDROXYPHENYL ALCANOID ACID ESTER WITH OXYETHYLATES OF POLYTHIOLS, PROCESS FOR THEIR PREPARATION AND USE AS STABILIZER | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-09-02 | — | — | EP | claimed |
| US-4906775-A | Esters of 3-tert-butyl- and 3-tert-butyl-5-alkyl-4-hydroxyphenyl (alkane) carboxylic acids with oxyethylates of polythiols | HUELS AKTIENGESELLSCHAFT (DE) | 1990-03-06 | — | — | US | claimed |
| EP-0268039-A2 | 3-Tert-butyl and 3-tert-butyl-5-alkyl-4-hydroxyphenyl alcanoid acid ester with oxyethylates of polythiols, process for their preparation and use as stabilizer | HÜLS AKTIENGESELLSCHAFT (DE) | 1988-05-25 | — | — | EP | claimed |
| US-3935198-A | BY HEATING THE PENICILLIN SULFOXIDE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-01-27 | — | — | US | claimed |
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-08-09 | — | — | US | disclosed |
| US-3935198-A | BY HEATING THE PENICILLIN SULFOXIDE | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | PIEZO1, ORAI2, VDAC2 | MEN1 1861/4885LMNA 1721/4885THRB 4748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.